Research programme: hepatitis B DNA vaccine - ViraxAlternative Names: Therapeutic HBV Vaccine - Virax; VIR 401
Latest Information Update: 10 Jan 2011
At a glance
- Originator Virax Holdings
- Developer Prescient Therapeutics
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Suspended Hepatitis B